CLDF Title
Home | Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Webcasts Slide Library Abstract Library Conference Highlights
Reuters Health Information (2009-08-14): Glaxo starts testing flu pandemic vaccine

Drug & Device Development

Glaxo starts testing flu pandemic vaccine

Last Updated: 2009-08-14 16:42:10 -0400 (Reuters Health)

LONDON (Reuters) - GlaxoSmithKline has started testing its pandemic H1N1 swine flu vaccine in humans and expects to start giving the results to government agencies next month, the drugmaker said on Friday.

Britain's Chief Medical Officer Liam Donaldson said on Thursday that vaccination would start for at-risk people in October, and Glaxo is expected to be the country's main supplier.

The company said that the first tests were being done on 128 healthy adults at a site in Germany, and in the next few weeks it would also start testing children and elderly people.

It plans to conduct 16 different trials of the vaccine and to test 9,000 people in total across Europe, Canada and the United States.

Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Regional Map
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.